PIEZO1 and prostate carcinoma: Similarly, a study on prostate cancer showed that Piezo1 downregulation inhibited the expression of Cyclin D1 and CDK4, hindering the assembly of the Cyclin D1-CDK4 complex and thus impeding cell cycle progression in prostate cancer cells (Han et al., 2019).